small molecule

MINOXIDIL EXTRA STRENGTH (FOR MEN)

MINOXIDIL

Loss of exclusivity—loss of exclusivity
CompanyTaro Pharmaceutical Industries →See this company's full patent-cliff portfolio

Drug detail

Brand nameMINOXIDIL EXTRA STRENGTH (FOR MEN)
Active ingredientMINOXIDIL
Strength5%
Dosage formSOLUTION
RouteTOPICAL
ModalitySmall molecule
FDA approvalJune 2025
Marketing statusOTC

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.